Axsome Therapeutics AXSM 深 沪
已收盘 08-14 16:00:00 美东时间
213.67
-0.010
0.00%
华盛通- 最 高216.30
- 今 开211.00
- 成交量 47.63万股
- 最 低 208.95
- 昨 收 213.68
- 总市值 109.95亿
- 52周最高 260.19
- 市盈率 静 --
- 换手率 0.93%
- 52周最低 112.90
- 委 比 99.26%
- 总股本 5145.98万
- 历史最高 260.19
- 量 比 0.46
- 振 幅 3.44%
- 历史最低 1.94
- 每 手 1
- 风险率 42.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results
Axsome Therapeutics Inc (NASDAQ:AXSM) on Monday posted downbeat results for the second quarter. The company reported quarterly losses of 99 cents per share which missed the analyst consensus estimate of losses of 83 cents per share. The company reported quarterly sales of $218.400 million which miss...
08-11 22:30
Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keefe, Bruyette & Woods raised the price target for Marketaxess Holdings Inc (NASDAQ:MKTX) from $150 to $167. ...
08-11 19:59
Needham Maintains Buy on Axsome Therapeutics, Raises Price Target to $268
Needham analyst Ami Fadia maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and raises the price target from $267 to $268.
08-11 18:24
财报速睇 | Axsome Therapeutics 2026财年Q2营收2.18亿美元，同比增长45.5%；归母净利润亏损0.51亿美元，同比亏损扩大7.0%
华盛资讯8月11日讯，Axsome Therapeutics公布2026财年Q2业绩，公司Q2营收2.18亿美元，同比增长45.5%，归母净利润亏损0.51亿美元，同比亏损扩大7.0%。
08-11 04:23
财报速睇 | Axsome Therapeutics 2026财年Q2营收2.18亿美元，同比增长45.5%；归母净利润亏损0.51亿美元，同比亏损扩大7.0%
华盛资讯8月10日讯，Axsome Therapeutics公布2026财年Q2业绩，公司Q2营收2.18亿美元，同比增长45.5%，归母净利润亏损0.51亿美元，同比亏损扩大7.0%。
08-10 19:20
Axsome Therapeutics Q2 EPS $(0.99) Misses $(0.83) Estimate, Sales $218.400M Miss $221.230M Estimate
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.83) by 19.28 percent. This is a 110.64 percent decrease over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $218.40...
08-10 19:01
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
